Signals from the tumor microenvironment, such as reduced TGF-β signaling, activation of NF-κB and STAT3 pathways, or stimulation by oncostatin M from tumor-associated macrophages and neutrophils, strongly upregulate CXCL1 expression in iCAFs. The gene discussed is TGFB1; the disease is neoplasm.